Looking for The right place in Europe for clinical trials?
All the right conditions
Continuous optimization of clinical trial processes and procedures, a highly-skilled workforce, excellent hospitals and researchers, and much more, makes Denmark a very attractive place for international Pharmaceutical & BioTech companies wanting to conduct clinical research and trials.
Denmark is an increasingly attractive location for businesses that depend on clinical trials. In recent years, the various Danish governments have taken active steps to boost the life science industry by building on the already strong national healthcare system and world-class environment for business and science. This also includes a keen political focus on continuously improving the framework conditions for conducting clinical trials in Denmark.
National entry point for companies
To make it easier and more attractive for global companies to conduct clinical trials in Denmark, a single entry point named Trial Nation was established in 2018. The services of Trial Nation includes:
- Investigator identification.
- A coordinated feasibility process with a national response from hospital sites within five days.
- Access to Trial Nations legal network offering legal advice and national contract negotiations.
- Access to established clinical specialty centers and national networks within oncology, hematology, dermatology, pediatrics, respiratory diseases, infectious diseases and dementia.
- And access to established partnerships with hospitals, scientists and patient networks – all free of charge.
Trial Nation has also a focus on clinical trials within the MedTech industry.
Proactive approach towards Decentralised clinical trials
Decentralised clinical trials (DCTs) introduce a revolution in the clinical trial industry by enabling faster trial execution, delivering more representative and diverse datasets, and providing clinical trials that are easily accessible and convenient for participants to take part in. Denmark is moving full speed ahead to become a global DCT frontrunner. The key to this is a close collaboration between authorities, clinicians, companies, and patients - especially the proactive role of the Danish Medicines Agency, which launched a DCT guideline in 2021.
Top 10 Reason for why your company should conduct clinical trials in Denmark:
get in touch Want to know more about clinical trials in Denmark?
Please contact our dedicated life science experts here: